1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
AN EVALUATION OF HUMAN PLACENTAL LACTOGEN LEVELS IN HYPERTENSION OF PREGNANCY
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1975.tb00633.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 82, Issue 4, pages 272–277, April 1975
Additional Information
How to Cite
Kelly, A. M., England, P., Lorimer, J. D., Ferguson, J. C. and Govan, A. D. T. (1975), AN EVALUATION OF HUMAN PLACENTAL LACTOGEN LEVELS IN HYPERTENSION OF PREGNANCY. BJOG: An International Journal of Obstetrics & Gynaecology, 82: 272–277. doi: 10.1111/j.1471-0528.1975.tb00633.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Abstract
- References
- Cited By
Summary
Maternal plasma levels of human placental lactogen (HPL) are decreased in hypertensive pregnancies and the concentration is related to the severity of the condition. Of infants who had HPL concentrations in the fetal danger zone (more than 2 SD's below normal mean) 75 per cent developed fetal distress, neonatal asphyxia or were light for dates. Patients who are identified in this way have lighter infants and placentae than their unidentified counterparts with normal HPL levels.